Literature DB >> 20546303

Exposure of IgG to an acidic environment results in molecular modifications and in enhanced protective activity in sepsis.

Iglika K Djoumerska-Alexieva1, Jordan D Dimitrov, Elisaveta N Voynova, Sebastien Lacroix-Desmazes, Srinivas V Kaveri, Tchavdar L Vassilev.   

Abstract

IgG molecules are exposed on a regular basis to acidic conditions during immunoaffinity purification procedures, as well as during the production of some therapeutic immunoglobulin preparations. This exposure is known to induce in them an antigen-binding polyreactivity. The molecular mechanisms and the possible biological significance of this phenomenon remain, however, poorly understood. In addition to the previously reported ability of these modified IgG antibodies to interact with a large panel of self-antigens, enhanced binding to non-self-antigens (bacterial), an increased ability to engage in F(ab')(2)/F(ab')(2) (idiotype/anti-idiotype) interactions and an increased functional antigen-binding affinity are reported here. The newly acquired 'induced polyreactivity' of low-pH buffer-exposed IgG is related to structural changes in the immunoglobulin molecules, and is at least partly attributable to the enhanced role of the hydrophobic effect in their interactions with antigen. Our results suggest that data from many previous studies on monoclonal and polyclonal IgG antibodies purified by low-pH buffer elution from protein A or protein G immunoaffinity columns should be reconsidered, as the procedure itself may have dramatically affected their antigen-binding behavior and biological activity. Low-pH buffer-treated pooled therapeutic immunoglobulins acquire novel beneficial properties, as passive immunotherapy with the pH 4.0 buffer-exposed, but not with the native therapeutic intravenous immunoglobulin preparation, improves the survival of mice with bacterial lipopolysaccharide-induced septic shock.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20546303     DOI: 10.1111/j.1742-4658.2010.07714.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  13 in total

1.  The Potential Role of Solvation in Antibody Recognition of the Lewis Y Antigen.

Authors:  Somdutta Saha; Ramachandran Murali; Anastas Pashov; Thomas Kieber-Emmons
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2015-10

2.  Antibody Purification Using Affinity Chromatography.

Authors:  Arabelle Cassedy; Richard O'Kennedy
Journal:  Methods Mol Biol       Date:  2022

3.  Lectin and Liquid Chromatography-Based Methods for Immunoglobulin (G) Glycosylation Analysis.

Authors:  Tea Petrović; Irena Trbojević-Akmačić
Journal:  Exp Suppl       Date:  2021

4.  Clinical and functional consequences of anti-properdin autoantibodies in patients with lupus nephritis.

Authors:  M Radanova; G Mihaylova; D Ivanova; M Daugan; V Lazarov; L Roumenina; V Vasilev
Journal:  Clin Exp Immunol       Date:  2020-05-07       Impact factor: 4.330

5.  Intravenous Immunoglobulin with Enhanced Polyspecificity Improves Survival in Experimental Sepsis and Aseptic Systemic Inflammatory Response Syndromes.

Authors:  Iglika Djoumerska-Alexieva; Lubka Roumenina; Anastas Pashov; Jordan Dimitrov; Maya Hadzhieva; Sandro Lindig; Elisaveta Voynova; Petya Dimitrova; Nina Ivanovska; Clemens Bockmeyer; Zvetanka Stefanova; Catherine Fitting; Markus Bläss; Ralf Claus; Stephan von Gunten; Srini Kaveri; Jean-Marc Cavaillon; Michael Bauer; Tchavdar Vassilev
Journal:  Mol Med       Date:  2016-03-31       Impact factor: 6.354

6.  The human natural anti-αGal antibody targets common pathogens by broad-spectrum polyreactivity.

Authors:  Jens Magnus Bernth Jensen; Sune Skeldal; Mikkel Steen Petersen; Bjarne Kuno Møller; Steen Hoffmann; Jens Christian Jensenius; Uffe B Skov Sørensen; Steffen Thiel
Journal:  Immunology       Date:  2021-01-04       Impact factor: 7.397

7.  Passive immunotherapy of sepsis with intravenous immune globulin: not all IVIg preparations are created equal.

Authors:  Tchavdar Vassilev; Michael Bauer
Journal:  Crit Care       Date:  2012-01-25       Impact factor: 9.097

Review 8.  Survival and digestibility of orally-administered immunoglobulin preparations containing IgG through the gastrointestinal tract in humans.

Authors:  Victoria S Jasion; Bruce P Burnett
Journal:  Nutr J       Date:  2015-03-07       Impact factor: 3.271

9.  Regenerable ZnO/GaAs Bulk Acoustic Wave Biosensor for Detection of Escherichia coli in "Complex" Biological Medium.

Authors:  Juliana Chawich; Walid M Hassen; Céline Elie-Caille; Thérèse Leblois; Jan J Dubowski
Journal:  Biosensors (Basel)       Date:  2021-05-07

10.  Effect of IVIG Formulation on IgG Binding to Self- and Exo- Antigens In Vitro and In Vivo.

Authors:  Susann Cattepoel; Annette Gaida; Alain Kropf; Marc W Nolte; Reinhard Bolli; Sylvia M Miescher
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.